Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 208

1.

Severity of tobacco abstinence symptoms varies by time of day.

Perkins KA, Briski J, Fonte C, Scott J, Lerman C.

Nicotine Tob Res. 2009 Jan;11(1):84-91. doi: 10.1093/ntr/ntn003.

2.
3.

Cotinine: effects with and without nicotine.

Hatsukami D, Pentel PR, Jensen J, Nelson D, Allen SS, Goldman A, Rafael D.

Psychopharmacology (Berl). 1998 Jan;135(2):141-50.

PMID:
9497019
4.

Reduction of tobacco withdrawal symptoms with a sublingual nicotine tablet: a placebo controlled study.

Molander L, Lunell E, Fagerström KO.

Nicotine Tob Res. 2000 May;2(2):187-91.

PMID:
11072457
5.

Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial.

Bullen C, McRobbie H, Thornley S, Glover M, Lin R, Laugesen M.

Tob Control. 2010 Apr;19(2):98-103. doi: 10.1136/tc.2009.031567.

PMID:
20378585
7.

Nicotine skin patch treatment increases abstinence, decreases withdrawal symptoms, and attenuates rewarding effects of smoking.

Levin ED, Westman EC, Stein RM, Carnahan E, Sanchez M, Herman S, Behm FM, Rose JE.

J Clin Psychopharmacol. 1994 Feb;14(1):41-9.

PMID:
8151002
8.

Smoking behavior on the first day of a quit attempt predicts long-term abstinence.

Westman EC, Behm FM, Simel DL, Rose JE.

Arch Intern Med. 1997 Feb 10;157(3):335-40.

PMID:
9040302
9.

[Smoking reduction and temporary abstinence: new approaches for smoking cessation].

Le Houezec J, Säwe U.

J Mal Vasc. 2003 Dec;28(5):293-300. Review. French.

PMID:
14978435
10.

Effects of instructions on responses to the nicotine patch: a laboratory study.

Fucito LM, Juliano LM.

Psychopharmacology (Berl). 2007 Nov;194(4):475-83.

PMID:
17619862
11.

The influence of transdermal nicotine on tobacco/nicotine abstinence and the effects of a concurrently administered cigarette in women and men.

Kleykamp BA, Jennings JM, Sams C, Weaver MF, Eissenberg T.

Exp Clin Psychopharmacol. 2008 Apr;16(2):99-112. doi: 10.1037/1064-1297.16.2.99.

PMID:
18489014
12.

Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.

Stapleton JA, Watson L, Spirling LI, Smith R, Milbrandt A, Ratcliffe M, Sutherland G.

Addiction. 2008 Jan;103(1):146-54.

PMID:
18028247
13.

A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation.

Prochazka AV, Kick S, Steinbrunn C, Miyoshi T, Fryer GE.

Arch Intern Med. 2004 Nov 8;164(20):2229-33.

PMID:
15534159
14.

High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking.

Rohsenow DJ, Monti PM, Hutchison KE, Swift RM, MacKinnon SV, Sirota AD, Kaplan GB.

Exp Clin Psychopharmacol. 2007 Feb;15(1):81-92.

PMID:
17295587
15.

Aiding reduction of smoking with nicotine replacement medications: hope for the recalcitrant smoker?

Fagerström KO, Tejding R, Westin A, Lunell E.

Tob Control. 1997 Winter;6(4):311-6.

16.

Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: results of a preliminary study.

McClernon FJ, Kollins SH, Lutz AM, Fitzgerald DP, Murray DW, Redman C, Rose JE.

Psychopharmacology (Berl). 2008 Mar;197(1):95-105.

PMID:
18038223
17.

Triple-combination pharmacotherapy for medically ill smokers: a randomized trial.

Steinberg MB, Greenhaus S, Schmelzer AC, Bover MT, Foulds J, Hoover DR, Carson JL.

Ann Intern Med. 2009 Apr 7;150(7):447-54.

PMID:
19349630
18.

Treatment of adolescent smokers with the nicotine patch.

Hanson K, Allen S, Jensen S, Hatsukami D.

Nicotine Tob Res. 2003 Aug;5(4):515-26.

PMID:
12959789
19.

Rate of nicotine onset from nicotine replacement therapy and acute responses in smokers.

Perkins KA, Lerman C, Keenan J, Fonte C, Coddington S.

Nicotine Tob Res. 2004 Jun;6(3):501-7.

PMID:
15203784
20.

A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.

O'Malley SS, Cooney JL, Krishnan-Sarin S, Dubin JA, McKee SA, Cooney NL, Blakeslee A, Meandzija B, Romano-Dahlgard D, Wu R, Makuch R, Jatlow P.

Arch Intern Med. 2006 Mar 27;166(6):667-74.

PMID:
16567607

Supplemental Content

Support Center